IP Library Granted Patent US 8,986,219
Granted Patent B2
US 8,986,219 · App. 14/034,913 · Granted Mar 24, 2015

Lumen occlusion detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,986,219
App. No.
14/034,913
Granted
Mar 24, 2015
Kind
B2
Abstract

Devices and methods are disclosed to detect or verify fallopian tube occlusion. Devices include an elongated body, a continuous open space extending between proximal and distal openings, a first pressure sensor or flow meter configured to measure a pressure or fluid flow within the continuous open space, at least one seal member protruding from the outer wall of the elongated body, and a second pressure sensor or flow meter configured to measure a pressure or flow meter within a space created by the at least one seal member.

Claims (28)

1. A method for determining fallopian tube occlusion using a pressure sensing probe, the probe comprising an elongate probe body having a sealing member disposed on, and protruding radially from, an outer surface of the probe body, the method comprising:

positioning a distal portion of the probe body in a fallopian tube, thereby isolating an interior volume of the fallopian tube bounded in part by the sealing member and the inner wall of the fallopian tube, wherein the sealing member comprises first and second annular seal members that define an annular space between the annular seal members and the interior wall of the fallopian tube when the distal portion of the probe is positioned within the fallopian tube;

administering a pressurized fluid into the isolated interior volume of the fallopian tube through a distal opening of the probe body located distally of the sealing member;

monitoring a pressure of the isolated interior volume of the fallopian tube to determine whether the fallopian tube is occluded; and

monitoring a seal formed between the sealing member and the inner wall of the fallopian tube to determine whether a pressure-tight seal is maintained by the sealing member while monitoring the pressure of the isolated interior volume of the fallopian tube, in order to verify that a decrease in pressure of the isolated interior volume of the fallopian tube is due to non-occlusion of the fallopian tube, wherein monitoring the seal formed between the sealing member and the inner wall of the fallopian tube comprises monitoring a pressure of the annular space.

2. The method of claim 1 , wherein one or both of the first and second annular seal members are inflatable.

3. The method of claim 1 , wherein the first and second annular seal members extend between about 3 mm and about 10 mm from the outer surface of the probe body.

4. The method of claim 1 , further comprising detecting tissue contact by the sealing member.

5. The method of claim 1 , wherein the fluid is administered to the isolated interior volume of the fallopian tube at a pressure within the range of 180 to 220 mm Hg.

6. The method of claim 1 , wherein the fluid is a gas.

7. The method of claim 1 , the probe body further having a proximal opening and a lumen that fluidly couples the proximal and distal openings, and wherein the pressure of the isolated interior region of the fallopian tube is monitored using a sensor located within the lumen.

8. The method of claim 1 , wherein the pressure of the annular space is monitored using a sensor located within the annular space.

9. A method for determining fallopian tube occlusion using an occlusion detecting probe, the probe comprising an elongate probe body having a sealing member disposed on, and protruding radially from, an outer surface of the probe body, the method comprising:

positioning a distal portion of the probe body in a fallopian tube thereby isolating an interior volume of the fallopian tube bounded in part by the sealing member and the inner wall of the fallopian tube, wherein the sealing member comprises first and second annular seal members that define an annular space between the annular seal members and the interior wall of the fallopian tube when the distal portion of the probe is positioned within the fallopian tube;

administering a pressurized fluid into the isolated interior volume of the fallopian tube through a distal opening of the probe body located distally of the sealing member;

monitoring a flow rate of the administered pressurized fluid to determine whether the fallopian tube is occluded; and

monitoring a seal formed between the sealing member and the inner wall of the fallopian tube to determine whether a fluid-tight seal is maintained by the sealing member while monitoring the flow rate of the administered pressurized fluid, in order to verify that a reduction in the flow rate of the administered pressurized fluid below a predetermined threshold is due to non-occlusion of the fallopian tube, wherein monitoring the seal formed between the sealing member and the inner wall of the fallopian tube comprises monitoring fluid flow into the annular space.

10. The method of claim 9 , wherein one or both of the first and second annular seal members are inflatable.

11. The method of claim 9 , wherein the first and second annular seal members extend between about 3 mm and about 10 mm from the outer surface of the probe body.

12. The method of claim 9 , further comprising detecting tissue contact by the sealing member.

13. The method of claim 9 , the probe body further having a proximal opening and a lumen that fluidly couples the proximal and distal openings, and wherein the flow rate of the administered pressurized fluid is monitored using a sensor located within the lumen.

14. The method of claim 9 , wherein the fluid flow within the annular space is monitored using a sensor located within the annular space.

15. A method for determining fallopian tube occlusion using an occlusion detection probe, the probe comprising an elongate probe body having a sealing member disposed on, and protruding radially from, an outer surface of the probe body, the method comprising:

positioning a distal portion of the probe body proximate a fallopian tube such that the sealing member isolates an interior volume of the fallopian tube bounded in part by sealing member and an inner wall of the fallopian tube, the sealing member comprising first and second annular seal members defining an annular space between the annular seal members and the interior wall of the fallopian tube when the distal portion of the probe is positioned within the fallopian tube;

administering a pressurized fluid into the isolated interior volume of the fallopian tube through a distal opening of the probe body located distally of the sealing member;

monitoring one of a pressure or flow rate of the pressurized fluid in the isolated interior volume of the fallopian tube to determine whether the fallopian tube is occluded; and

monitoring one of a pressure of, or a flow rate within, the annular space defined by the first and second sealing members to determine whether a fluid-tight seal is maintained by the sealing member while monitoring the pressure or flow rate of the pressurized fluid introduced into the isolated interior volume of the fallopian tube.

16. The method of claim 15 , wherein the pressure of, or flow rate within, the annular space is monitored using a sensor located within the annular space.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE R/F 031746 0514 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036127/0671 →
SECURITY AGREEMENT Recorded Dec 2, 2013
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 031746/0514 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2013
From: LAYTON, RUSSELL
To: HOLOGIC, INC.
Reel/Frame 031513/0090 →